Search results
Results from the WOW.Com Content Network
The American Society of Hematology (ASH) is a professional organization representing hematologists, founded in 1958. Its annual meeting is held in December of every year and has attracted more than 30,000 attendees. [ 1 ]
Blood is a peer-reviewed medical journal published by the American Society of Hematology.It was established by William Dameshek in 1946. The journal changed from semimonthly (24 times annually) to weekly publication at the start of 2009.
He was granted fellowship by the American Association for the Advancement of Science [6] in 1998, and membership by the National Academy of Medicine in 2013. [5] [3] Sadler was president of the American Society of Hematology and won the organization's Henry M. Stratton Medal for Basic Science in 2016, [7] followed by its Exemplary Service Award ...
American Journal of Hematology is an academic journal devoted to the coverage of blood diseases. It has been published since 1976. The editor-in-chief is Carlo Brugnara (Harvard Medical School). [1] According to the Journal Citation Reports, the journal has a 2022 impact factor of 12.8, ranking it 7th out of 76 journals in the category ...
Dunbar is currently the Secretary of the American Society of Hematology. She was the President of the American Society of Gene and Cell Therapy. [2] She was a faculty member for the ASH-European Hematology Association Translational Research Training in Hematology program from 2011 to 2016 and was co-director in 2016. [5]
Jonathan D. Licht is an American physician who has served as director of the University of Florida Health Cancer Center since 2015, holding The Marshall E. Rinker Sr. Rinker Chair. [1] Licht led the UF Health Cancer Center to achieve designation from the National Cancer Institute in June 2023.
The Company recently presented updated results from the ongoing ALLOHA trial of TSC-100 and TSC-101 at the 66 th American Society of Hematology (ASH) Annual Meeting and Exposition. Infusions with TSC-100 and TSC-101 were well-tolerated with no dose limiting toxicities and adverse events were consistent with hematopoietic cell transplantation (HCT).
William Dameshek (1900 in Voronezh – 1969) was an American hematologist. He graduated from Harvard College and Harvard Medical School and spent the early part of his career at Beth Israel Hospital (now Beth Israel Deaconess Medical Center). [1] He was the founder of Blood, the prime core clinical